Imexpharm Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Revenue	2,083,396	1,994,037	1,643,707	1,266,597	1,369,422	1,402,454	Upgrade
Revenue Growth (YoY)	10.00%	21.31%	29.77%	-7.51%	-2.36%	18.37%	Upgrade
Cost of Revenue	1,122,502	1,010,064	824,152	669,657	750,104	763,396	Upgrade
Gross Profit	960,894	983,973	819,555	596,940	619,318	639,058	Upgrade
Selling, General & Admin	609,130	602,926	523,055	362,868	356,763	436,016	Upgrade
Operating Expenses	609,130	602,926	523,055	362,868	356,763	436,016	Upgrade
Operating Income	351,764	381,047	296,500	234,072	262,555	203,042	Upgrade
Interest Expense	-4,642	-6,036	-3,795	-5,496	-5,408	-3,728	Upgrade
Interest & Investment Income	12,268	19,877	19,853	12,364	7,015	7,015	Upgrade
Currency Exchange Gain (Loss)	497.75	2,613	-2,053	3,436	1,882	2,008	Upgrade
Other Non Operating Income (Expenses)	-18,609	-20,221	-19,448	-9,413	-10,173	-5,811	Upgrade
EBT Excluding Unusual Items	341,279	377,279	291,059	234,963	255,870	202,526	Upgrade
Gain (Loss) on Sale of Investments	1.51	-6.02	345.28	3,896	-429.04	-96.97	Upgrade
Gain (Loss) on Sale of Assets	-2,312	-	-	-	-	-	Upgrade
Pretax Income	338,968	377,273	291,404	238,859	255,441	202,429	Upgrade
Income Tax Expense	69,070	77,717	67,864	49,764	45,744	40,042	Upgrade
Net Income	269,898	299,556	223,540	189,095	209,697	162,387	Upgrade
Preferred Dividends & Other Adjustments	42,777	44,933	39,697	15,582	30,039	19,486	Upgrade
Net Income to Common	227,121	254,623	183,844	173,513	179,658	142,900	Upgrade
Net Income Growth	-4.23%	34.01%	18.22%	-9.82%	29.13%	17.09%	Upgrade
Shares Outstanding (Basic)	154	154	154	154	150	148	Upgrade
Shares Outstanding (Diluted)	154	154	154	154	150	148	Upgrade
Shares Change (YoY)	-2.93%	-	-0.00%	2.92%	0.86%	0.01%	Upgrade
EPS (Basic)	1474.72	1653.28	1193.71	1126.63	1200.54	963.11	Upgrade
EPS (Diluted)	1474.62	1653.18	1193.64	1126.63	1200.43	963.11	Upgrade
EPS Growth	-7.86%	38.50%	5.95%	-6.15%	24.64%	17.09%	Upgrade
Free Cash Flow	17,109	-103,064	279,250	182,024	-16,531	-64,535	Upgrade
Free Cash Flow Per Share	111.09	-669.21	1813.19	1181.89	-110.47	-434.95	Upgrade
Dividend Per Share	454.546	454.546	432.901	649.351	649.351	333.000	Upgrade
Dividend Growth	5.00%	5.00%	-33.33%	0%	95.00%	-50.00%	Upgrade
Gross Margin	46.12%	49.35%	49.86%	47.13%	45.22%	45.57%	Upgrade
Operating Margin	16.88%	19.11%	18.04%	18.48%	19.17%	14.48%	Upgrade
Profit Margin	10.90%	12.77%	11.18%	13.70%	13.12%	10.19%	Upgrade
Free Cash Flow Margin	0.82%	-5.17%	16.99%	14.37%	-1.21%	-4.60%	Upgrade
EBITDA	455,982	463,034	356,886	294,484	315,916	244,251	Upgrade
EBITDA Margin	21.89%	23.22%	21.71%	23.25%	23.07%	17.42%	Upgrade
D&A For EBITDA	104,217	81,987	60,386	60,412	53,361	41,209	Upgrade
EBIT	351,764	381,047	296,500	234,072	262,555	203,042	Upgrade
EBIT Margin	16.88%	19.11%	18.04%	18.48%	19.17%	14.48%	Upgrade
Effective Tax Rate	20.38%	20.60%	23.29%	20.83%	17.91%	19.78%	Upgrade
Revenue as Reported	2,083,396	1,994,037	1,643,707	1,266,597	1,369,422	1,402,454	Upgrade
Advertising Expenses	-	175,099	123,665	110,468	74,360	113,944	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.